Industry
Biotechnology
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
June 05, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Insights
May 29, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
May 15, 2024 | 8:21 pm
Portfolio Pulse from Benzinga Newsdesk
May 15, 2024 | 8:20 pm
Portfolio Pulse from Benzinga Newsdesk
May 15, 2024 | 8:02 pm
Portfolio Pulse from Benzinga Insights
April 19, 2024 | 12:08 pm
Portfolio Pulse from Benzinga Newsdesk
April 16, 2024 | 7:52 pm
Portfolio Pulse from Benzinga Newsdesk
April 16, 2024 | 3:35 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.